TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
FLNA

Filana Therapeutics, Inc.

Healthcare · Biotechnology

0.7728$ -11.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Filana Therapeutics, Inc. (FLNA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 118 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet FLNA
Line item 2021 2022 2023 2024 2025
– 235 152 158 118
– 211 130 137 98
– 201 121 129 96
– – – – 96
– – – – 0.1
– 0.6 0.2 0.0 –
– 7.3 14 12 44
– 7.1 14 12 44
– 4.0 11 7.7 6.4
– 228 137 146 74
– -284 -381 -405 -496
39 40 42 4,660 48

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?